NEW YORK, May 14, 2024 /PRNewswire/ — The global flow cytometry market size is estimated to grow by USD 6038.44 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of about 13.12% during the forecast period.
For more insights on the forecast market size and historic data (2017 – 2021) – Download Free sample report in a minutes
|
Forecast period |
2023-2027 |
|
Base Year |
2022 |
|
Historic Data |
2017 – 2021 |
|
Segment Covered |
Product (Reagents and consumables, Instruments, and Others ), End-user (Pharmaceutical industry, Health and diagnostic centers, and Others ), and Geography (North America, Europe, Asia, and Rest of World (ROW)) |
|
Region Covered |
North America, Europe, Asia, and Rest of World (ROW) |
|
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. And Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc. |
Key Market Trends Fueling Growth
Flow cytometry, a crucial technology in life science and biopharmaceutical research, has witnessed significant automation over the past few decades. From manual sample preparation and loading to advanced instruments for sample preparation, loading, and storage, the market has seen substantial growth. These digital devices reduce human intervention, offer seamless integration with other processes, and decrease processing time and supervision. Key applications include multiparametric data analysis, stem cell cultures, and fluorescent-labeled antibodies. Flow cytometry services cover various sectors like cancer, HIV, drug discovery, and immune disorders. Innovations include microfluidic flow cytometry, liquid handling robotics, and cellular diagnostics. Fluorochrome combinations and flow cytometric services are essential components of this market. PCR and antibody-based testing are additional applications.
Market Challenges
* Flow cytometers are increasingly utilized in drug discovery and development due to their analytical capabilities.
* The high cost of flow cytometer instruments is a significant challenge to market growth.
* Costs vary based on type and brand, with an average price ranging from $100,200 to $500,200 per unit.
* Additional expenses include reagents, markers, consumables, and software support.
* The average cost of a flow cytometry kit is approximately $220–$230.
* Large initial investment required for procurement, setup, and calibration.
* Instruments have a useful life of six to eight years, with a low probability of replacement within the first five years.
* Innovation in product features, digitization, and accessories leads to faster obsolescence and shorter replacement cycles.
* Total ownership cost is high, particularly in healthcare and pharmaceutical sectors.
* Cost of flow cytometer instruments, along with additional components and maintenance, may hinder market growth.
Research report provides comprehensive data on impact of trend, driver and challenges – Buy Report
Segment Overview
This flow cytometry market report extensively covers market segmentation by
- Product
- 1.1 Reagents and consumables
- 1.2 Instruments
- 1.3 Others
- 2.1 Pharmaceutical industry
- 2.2 Health and diagnostic centers
- 2.3 Others
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Reagents and consumables- The flow cytometry market segment encompasses a range of products essential for this technique, including reagents and consumables, digital signal processing instruments, data analysis solutions, software, and accessories. These products cater to various applications in the healthcare sector, particularly in the diagnosis and monitoring of infectious diseases such as AIDS and tuberculosis, as well as sexually transmitted diseases. In drug development activities, cell-based flow cytometry and bead-based assays are employed for stem cell cultures and the analysis of multiparametric data. Flow cytometers, fluorescent-labeled antibodies, and fluorescent-labeled compounds are integral components of this market, enabling the detection of conditions like cancer and HIV. Control parameters and flow cytometry services are also crucial for ensuring accurate results. Flow cytometry innovators and contract service providers offer flow cytometry analysis, techniques such as Western blotting and immunohistochemistry, and microscopy services to cater to the growing demand for these instruments in clinical testing labs. The market is driven by the increasing prevalence of autoimmune disorders, leukemia, lymphoma, and other diseases, as well as the need for rapid point-of-care diagnostics.
For more information on market segmentation with geographical analysis including forecast (2023-2027) and historic data (2017 – 2021) – Download a Sample Report
Research Analysis
The Flow Cytometry Market encompasses the use of multiparametric data analysis solutions for stem cell research, including the application of fluorescent-labeled antibodies and compounds in flow cytometry services. Flow cytometry technique is a crucial tool in life science, biotechnology, and biopharmaceutical research activities, enabling the analysis of various cell types and their characteristics. Flow cytometer instruments are employed in the diagnosis and monitoring of autoimmune disorders, infectious diseases such as AIDS, and cancer, as well as immunodeficiency disorders. Microfluidic flow cytometry and PCR are advanced technologies used in this field, while antibody-based testing is a common application. Western blotting and immunohistochemistry, along with microscopy, serve as complementary techniques for further investigation. Control parameters ensure accurate and reliable data analysis.
Market Research Overview
The Flow Cytometry Market refers to the global industry dedicated to the production, sale, and use of flow cytometry instruments and related consumables. These technologies enable the analysis of cellular components in various fields, including immunology, hematology, and research. The market is driven by factors such as increasing research and development activities, rising demand for personalized medicine, and technological advancements. Flow cytometry techniques offer high-speed analysis, multi-parameter detection, and the ability to sort cells based on specific characteristics. The market encompasses various components, including instruments, reagents, and software, and serves a diverse range of end-users, including academic and research institutions, hospitals, and pharmaceutical and biotechnology companies.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
- Reagents And Consumables
- Instruments
- Others
- End-user
- Pharmaceutical Industry
- Health And Diagnostic Centers
- Others
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
